Investigator(s):
The Lundquist Institute
LA BioMed Researchers Find Novel NDV-3 Vaccine Protects Against MRSA
LOS ANGELES – (Dec. 8, 2014) – In the U.S. and around the globe, skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA) continue to endanger the health and lives of patients and otherwise healthy individuals. Treatment is difficult because MRSA is resistant to many antibiotics, and the infections can recur, placing family members and other close contacts at risk of infection.
Deriving physiologic first principles
Both the developmental and phylogenetic histories of an organism describe the evolution of physiology—the complex of metabolic pathways that govern the function of an organism as a whole. The necessity of establishing and maintaining homeostatic mechanisms began at the cellular level, with the very first cells, and homeostasis provides the underlying selection pressure fueling evolution.
Investigator(s):
The Lundquist Institute
LOS ANGELES – Los Angeles Biomedical Research Institute (LA BioMed) announced today that it will receive Phase II funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables individuals worldwide to test bold ideas to address persistent health and development challenges. Frans J. Walther, MD, PhD, an LA BioMed lead researcher, will continue to pursue an innovative global health research project, titled “Aerosol Delivery of Synthetic Lung Surfactant.”
LA BioMed Partnering with QT Medical to Identify Infants at Risk of Long QT Syndrome
LOS ANGELES – (Oct. 28, 2014) –Each year, some 2,000 babies are born in the U.S. with a genetic heart condition, known as long QT syndrome. If not diagnosed in time, babies with long QT syndrome can die from a sudden arrhythmia, or irregular heartbeat.
Event also Will Recognize Dr. John Michael Criley for His Leadership
LOS ANGELES – (September 24, 2014) – On Oct. 18 at its Advancing Innovation Gala, Los Angeles Biomedical Research Institute (LA BioMed) will recognize three champions of innovation who are leading companies built on research conducted at LA BioMed: Timothy Cooke, PhD., Keith Leonard and Yutaka Niihara, MD.
The Advancing Innovation Gala also will honor John Michael Criley, MD, an LA BioMed Legend and researcher, who pioneered the modern U.S. paramedic model of providing emergency care.
Researchers Identify Why Hospitals May Not “Get in the Ring” to Fight “Superbug”
PHILADELPHIA – (Oct. 8, 2014) – Numerous experts and policy makers have called for hospitals to screen patients for methicillin-resistant Staphylococcus aureus (MRSA) infections and isolate anyone testing positive to prevent the spread of these so-called “Superbugs” in healthcare settings. Several states have enacted laws requiring patients be screened for MRSA upon admission.
LA BioMed Researchers Surveyed Emergency Patients Tested for THC Levels
LOS ANGELES – (Oct. 1, 2014) – Surveying patients with traumatic brain injury, a group of Los Angeles Biomedical Research Institute (LA BioMed) researchers reported today that they found those who tested positive for THC, the active ingredient in marijuana, were more likely to survive than those who tested negative for the illicit substance.
Investigator(s):
The Lundquist Institute
Researchers Find Method for Replacing Missing Enzyme in the Brain.
LOS ANGELES – (Oct. 1, 2014) – MPS IIIB is a devastating and currently untreatable disease that causes progressive damage to the brain, leading to profound intellectual disability, dementia and death — often before reaching adulthood.
Patients benefit from minimally invasive procedures.
LOS ANGELES – (September 23, 2014) –
Laparoscopic cholecystectomy, a minimally invasive procedure to remove the gallbladder, is one of the most common abdominal surgeries in the U.S. Yet medical centers around the country vary in their approaches to the procedure with some moving patients quickly into surgery while others wait.
New Research Executive Brings Wealth of Experience to Institute
LOS ANGELES – (August 18, 2014) – Bringing a wealth of experience in research administration, Susan D. Rubin recently joined Los Angeles Biomedical Research Institute (LA BioMed) in a newly created role of chief operating officer and general counsel.